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Global research collaborations 
a b s t r a c t 
Neuroimaging genetics is a rapidly developing field that combines neuropsychiatric genetics studies with imag- 
ing modalities to investigate how genetic variation influences brain structure and function. As both genetic and 
imaging technologies improve further, their combined power may hold translational potential in terms of im- 
proving psychiatric nosology, diagnosis, and treatment. While neuroimaging genetics studies offer a number of 
scientific advantages, they also face challenges. In response to some of these challenges, global neuroimaging 
genetics collaborations have been created to pool and compare brain data and replicate study findings. Attention 
has been paid to ethical issues in genetics, neuroimaging, and multi-site collaborative research, respectively, but 
there have been few substantive discussions of the ethical issues generated by the confluence of these areas in 
global neuroimaging genetics collaborations. Our discussion focuses on two areas: benefits and risks of global 
neuroimaging genetics collaborations and the potential impact of neuroimaging genetics research findings in low- 
and middle-income countries. Global neuroimaging genetics collaborations have the potential to enhance rela- 
tions between countries and address global mental health challenges, however there are risks regarding inequity, 
exploitation and data sharing. Moreover, neuroimaging genetics research in low- and middle-income countries 
must address the issue of feedback of findings and the risk of essentializing and stigmatizing interpretations of 
mental disorders. We conclude by examining how the notion of solidarity, informed by an African Ethics frame- 






































Neuroimaging genetics, also referred to as neuroimaging genomics,
s rapidly and effectively developing to combine neuropsychiatric genet-
cs studies with imaging modalities to investigate how genetic variation
nfluences brain structure and function. One key hypothesis is that in
he case of neuropsychiatric disorders which lack definitive biomarkers,
maging provides a number of intermediate traits, or endophenotypes,
hat may be more proximal to the genetic substrate of the disorder than
 behavioural phenotype ( Thompson et al., 2010 , Roiser, 2011 ). This
loser proximity could assist in more effectively pinpointing the genes
hat contribute to these disorders ( Thompson et al., 2010 , Rose and
onohoe, 2013 ). As both genetic and imaging technologies improve fur-
her, their combined power may hold translational potential in terms
f improving psychiatric nosology, diagnosis, treatment, and ultimately
revention of neuropsychiatric disorders ( Bogdan et al., 2017 ). ∗ Corresponding author. 
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 http://creativecommons.org/licenses/by-nc-nd/4.0/ ) While neuroimaging genetics studies offer a number of scientific ad-
antages ( Hariri and Weinberger, 2003 ), they also face various chal-
enges ( Bogdan et al., 2017 ). The high cost of imaging studies, for ex-
mple, places limits on sample size, impacting ability to identify robust
orrelations ( Mohammadi, 2015 ) and posing challenges for the repli-
ation of findings ( Thompson et al., 2014 ). In response to these chal-
enges, global neuroimaging genetics networks have been created to
ool and compare brain data and replicate study findings. These include
he ENIGMA, IMAGEN ( Nymberg et al., 2013 ), CHARGE ( Davies et al.,
015 ) and GIGA consortia. Formed in 2009 and building on the work of
arlier international brain mapping consortia ( Mazziotta et al., 2009 ),
NIGMA (Enhancing Neuroimaging Genetics through Meta-Analysis) is
he oldest and largest of the neuroimaging genetics consortia, with mem-
ership currently including approximately 2,025 researchers from 45
ountries across the globe ( Thompson et al., 2020 ) (see world map of
NIGMA’s working group locations, Fig. 1 ). ENIGMA provides a use-
ul exemplar for considering some of the ethical issues raised by global
euroimaging genetics collaborations. 0 
ticle under the CC BY-NC-ND license. 
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p  The ethical implications elicited by imaging genetics call for what
airyan and Illes describe as “an expanded neuro-space’’ ( Tairyan and
lles, 2009 ). This refers to “the ethics environment generated by the com-
lex interaction of genetics, neural systems and behaviour ” ( Tairyan and
lles, 2009 ). Their analysis was the first to address issues raised by this
onfluence of genethics and neuroethics and aimed to serve as a point
f departure for further discussion. While the number of neuroimaging
enetics studies has increased considerably since their paper in 2009,
here have been surprisingly few subsequent discussions devoted specif-
cally to ethical issues in this area. Furthermore, to our knowledge, there
ave been few discussions in the literature of the ethical issues raised by
lobal neuroimaging genetics collaborations in particular. While consid-
rable attention has been paid to ethical issues in genetics, imaging, and
ulti-site collaborative research respectively, it is worth considering the
mplications of the convergence of these distinct areas. 
We begin our discussion with an overview of neuroimaging genetics.
e then focus on ethical issues in two areas. First, we discuss bene-
ts and risks of global neuroimaging genetics collaborations . While
here are numerous possible ethical issues in this area, we limit our dis-
ussion to two aspects that have potential for both benefit and risk: (1)
he potential of global neuroimaging genetics collaborations to enhance
elations between countries and address global mental health chal-
enges, and concerns about inequity and exploitation associated with
uch collaborations, and (2) benefits and risks posed by data sharing.
econd, we discuss the potential impact of neuroimaging genet-
cs research findings in low- and middle-income countries (LMICs ).
ere we discuss the issue of feedback of findings and the risk of es-
entializing and stigmatizing interpretations of mental disorders arising
rom neuroimaging genetics studies. Throughout our discussion, where
ow-resourced contexts are discussed, we take African contexts as our
oint of departure. We conclude by examining how the notion of
olidarity, informed by an African Ethics framework, may justify
ome of the suggestions made in our discussion. 
. An overview of neuroimaging genetics 
The field of neuroimaging genetics is approximately twenty years
ld. Initial studies followed the single variant approach, focusing onssociations between candidate genes, with known functions, and neu-
al systems ( Bookheimer et al., 2000 ) (e.g., the effects of variants of the
atechol-O-methyltransferase ( COMT ) gene on brain structure and func-
ion in conferring risk for schizophrenia ( Hariri and Weinberger, 2003 ,
ashimoto et al., 2015 ). While initial candidate studies indicated the
eritability of brain measures ( Jansen et al., 2015 ), they were hampered
y small effect sizes, difficulties in replicating findings, and concerns of
ublication bias ( Bogdan et al., 2017 , Mufford et al., 2017 ), and indeed
any apparently promising findings have since been abandoned or re-
uted ( Border et al., 2019 , Jahanshad et al., 2017 ). With the ability to
equence the entire genome, the single variant approach was largely re-
laced by genome wide association studies (GWAS). From neuroimaging
ata such as MRI, DTI and resting state functional MRI, it was possible
o derive “objectively measurable ”, quantitative traits or markers to in-
rease the power of GWAS ( Potkin et al., 2009 ). However, these stud-
es were still underpowered due to small sample sizes ( Bogdan et al.,
017 , Thompson et al., 2014 ). This led to the formation of collaborative
euroimaging genetics consortia, such as ENIGMA, and the adoption of
 meta-analysis approach, which combines results across different re-
earch sites in order to increase statistical power. 
Currently, ENIGMA comprises 51 working groups, 32 of which are
ocused on neurological and psychiatric disorders ( Thompson et al.,
020 ). To date, the consortium has produced the largest structural MRI
tudies of major depressive disorder (MDD) ( Schmaal et al., 2017 ),
chizophrenia ( van Erp et al., 2016 ), bipolar disorder ( Hibar et al.,
018 ), obsessive-compulsive disorder ( Boedhoe et al., 2017 ), attention
eficit/hyperactivity disorder ( Hoogman et al., 2017 ), posttraumatic
tress disorder ( Morey et al., 2017 ), epilepsy ( Whelan et al., 2018 ),
2q11.2 deletion syndrome ( Sun et al., 2018 ), substance use disorders
 Mackey et al., 2019 ), and autism spectrum disorders ( van Rooij et al.,
018 ), combining data from more than 50 000 individuals. The find-
ngs of these studies indicate quantitative differences in brain structure
nd function, which can assist in identifying the nature and magnitude
f those differences, despite the absence of “objective laboratory diag-
ostic test[s] ” ( Bearden and Thompson, 2017 ). These studies also in-
icate commonalities among certain disorders (e.g., MDD, schizophre-
ia and bipolar disorder are all associated with deficits in hippocam-
al volume ( Opel et al., 2020 )) which are consistent across the globe


























































































































o   Koshiyama et al., 2020 ), as well as important differences between disor-
ers ( Bearden and Thompson, 2017 ). There are also working groups fo-
using on a range of methodological issues and approaches ( Bearden and
hompson, 2017 ). 
Neuroimaging genetics combines two highly complex and distinct
pproaches to identifying and understanding disease pathways, each
f which faces its own technical challenges. The development of non-
nvasive imaging modalities has yielded increasingly sensitive in vivo
tudy of the neuroanatomy of neurological and psychiatric disorders.
aution has, however, been called for regarding the findings of such
tudies ( Weinberger and Radulescu, 2016 ), given that MRI signals are
usceptible to numerous confounding variables including weight, fit-
ess, alcohol, drug and nicotine use, stress levels, and mental state, as
ell as artifacts such as head movement and breathing ( Mufford et al.,
017 , Weinberger and Radulescu, 2016 ). 
Progress has also been made in deepening understanding of the
enetic basis of psychiatric disorders ( Sullivan et al., 2018 ). GWAS,
nd, more recently, whole-exome sequencing studies (WES) have played
 key role in identifying common genetic variants that contribute to
omplex disease risk. However, given the small effect sizes of most
isk variants, GWAS require large samples of cases and controls. De-
pite their widespread use there is also scepticism regarding the abil-
ty of case-control GWA studies to adequately explain the genetic ba-
is of common complex diseases ( McClellan and King, 2010 ). A major
urdle that has faced association studies is the issue of missing her-
tability ( Manolio et al., 2009 ); a disorder such as schizophrenia, for
xample, is approximately 80% heritable but a large Psychiatric Ge-
omics Consortium (PGC) study of schizophrenia, demonstrated that
ommon variants only accounted for approximately 30% of the heri-
ability ( Schizophrenia Working Group of the Psychiatric Genomics Con-
ortium 2014 , Rhoades et al., 2019 ). 
Consortia such as ENIGMA have made major advances in es-
ablishing the genetic architecture of neuroimaging phenotypes
 Satizabal et al., 2017 , Hofer et al., 2019 , Grasby et al., 2020 ). In ad-
ition to the studies mentioned above, an ENIGMA study that included
WAS data from over 40 000 individuals identified 45 significant loci
hat impact subcortical structures in the brain involved in movement,
earning, memory and motivation ( Satizabal et al., 2017 ). A more recent
tudy of over 50 000 people – from 60 worldwide cohorts – discovered
ver 200 genetic loci associated with cortical gray matter thickness and
urface area ( Grasby et al., 2020 ). These genetic markers significantly
verlapped with loci that confer genetic risk for insomnia, ADHD, and
arkinson’s disease. These findings have implications for a deeper un-
erstanding of the causes of differential brain development and path-
ays of neuropsychiatric dysfunction. Still, neuroimaging genetics stud-
es are typically characterized by small effect sizes 1 ( Bogdan et al., 2017 ,
ashimoto et al., 2015 ). However, further research as well as the devel-
pment of new models and methods will continue to address these chal-
enges ( Grasby et al., 2020 , Smeland et al., 2018 , Franke et al., 2016 ,
an der Merwe et al., 2019 ). 
. The benefits and risks of global collaborations in 
euroimaging genetics 
There is a growing body of literature that addresses ethical issues in
lobal research collaborations involving multiple sites and institutions
n both high-income countries (HICs) and low- and middle-income coun-
ries (LMICs) ( Parker and Bull, 2009 , Schroeder et al., 2018 ) as well as
thical challenges associated specifically with genetics research in the
ontext of such collaborations ( de Vries et al., 2011 , Munung et al.,
017 ). We build on these discussions by examining how the combina-
ion of neuroimaging and genetics adds to the ethical complexity. In1 There are exceptions e.g., variants in the APOE 𝜀 4 gene and copy number 
ariants (CNVs) which may have substantial effect sizes ( Sønderby et al., 2018 , 




fi  his section we look at two ethical issues that are internal to such col-
aborations: the benefits and risks of collaborations and data sharing,
espectively. 
.1. Science diplomacy and collective problem solving 
The challenges facing humanity require global effort and collabora-
ion between nations ( Schroeder et al., 2018 ). Recognition of this has
een a major driver in global mental health ( Patel and Prince, 2010 ). A
enefit that is sometimes overlooked in global scientific collaborations is
he way in which they are able to build and enhance diplomatic relations
nd transcend political conflicts between nations. Science diplomacy is
efined as “the use of scientific collaborations among nations to address
he common problems facing … humanity and to build constructive in-
ernational partnerships ” ( Fedoroff, 2009 ). The value of scientific coop-
ration was highlighted during the Cold War with concerted efforts of
oviet and American scientists working on a vaccine for the polio virus
 The Editors, 2017 ). In the context of twenty-first century conflicts be-
ween nations, scientific collaborations may be a way of bridging polit-
cal conflicts between nations. With representation from 45 countries,
ome of which have minimal diplomatic ties, membership in a consor-
ium such as ENIGMA is a way of, at the very least, keeping channels
pen between nations. 
Scientific collaborations are not only constructive in terms of build-
ng diplomatic relations between conflicting nations, they also facilitate
xpertise-sharing. This leads to a more constructive form of collective
roblem solving whereby results are considered from different perspec-
ives and disciplinary backgrounds, enabling innovative insights and ap-
roaches to be developed. In addition to these benefits, scientific collab-
rations have the potential to facilitate connections between HICs and
he poorest nations across the globe and to build capacity in the lat-
er ( Fedoroff, 2009 , Zewail, 2010 ). For example, while the majority of
NIGMA sites are located in North America, Europe and Australia, the
onsortium also has members in the Middle East, Russia, and in LMICs in
sia, including India, and South America. While there are African mem-
ers, the continent is conspicuously underrepresented. This is unsurpris-
ng, however, given the scarcity of MRI scanners in Africa ( Ogbole et al.,
018 ), and in particular, the lack of high field strength scanners suitable
or research purposes ( Spottiswoode and Carey, 2008 ). 
Insofar as neuroimaging genetics studies have long-term potential
o contribute to improved understanding and treatment of neuropsychi-
tric disorders, the underrepresentation of African participants in such
tudies is a potential source of health inequity. The gap between devel-
ping nations, and Africa in particular, and developed nations in the
esearch and treatment of mental illnesses has been emphasized previ-
usly ( Sankoh et al., 2018 , Demyttenaere et al., 2004 ). Such disparities
lso exist within nations, with many indigenous populations and racial-
thnic minority populations experiencing inequitable access to mental
ealthcare ( McIntyre et al., 2017 , Cook et al., 2017 ). This gap and recog-
ition that a lack of access to mental health care constitutes a violation
f the fundamental human right to mental health has been pivotal in
otivating global mental health ( Patel and Prince, 2010 , Patel et al.,
018 ). The research gap has also been highlighted in genomics research
 Martin et al., 2018 ). Genomics studies have mostly been conducted in
ICs and, even within these countries, have predominantly included
articipants with European ancestry, therefore, any insights, predictive
bility or potential clinical utility gained from these studies may be lim-
ted to these populations ( Martin et al., 2018 ). The same concern holds
or the need for knowledge of the effects of ancestry-specific variants
n the brain ( Tairyan and Illes, 2009 ). Addressing global inequities in
ental health will require not only increasing the number of scanners
n the African continent but also investing in the infrastructure capable
f supporting such equipment and the requisite expertise to operate it. 
While global science collaborations have the potential to address
lobal health inequities, such collaborations have also been identi-
ed as contexts of potential exploitation of LMICs or ‘ethics dumping’


































































































































o   Schroeder et al., 2018 ). The latter refers to the tendency of researchers
r institutions in HICs to take advantage of a lack of ethics oversight
nd governance structures in low-resourced countries in order to under-
ake or export research, (e.g. clinical trials), that would be either illegal
r ethically untenable in their own countries ( Schroeder et al., 2018 ,
awkins and Emanuel, 2008 ). While exploitation of LMICs may not be
ntentional, there is a risk of inadvertent exploitation. This may be due
o a lack of awareness on the part of HIC researchers or institutions of
elevant contextual information such as salient cultural factors or local-
zed ethical challenges. 
In order to safeguard against both intentional and unintentional ex-
loitation, equity in international research has become a driving force
 Parker and Bull, 2009 , Schroeder et al., 2018 ). This includes creating
wareness among researchers of the potential for exploitation and the
eed for contextual sensitivity, capacity building of ethics oversight and
esearch ethics committees in such countries, and the introduction of
compliance mechanisms ” ( Schroeder et al., 2018 ). Examples of the lat-
er include implementing sound ethics frameworks for governance and
est practice of research in LMICs (see ( Yakubu et al., 2018 )), intro-
ucing and developing national guidelines, and by funders and insti-
utions adopting and enforcing codes of conduct. The Global Code of
onduct for Research in Resource-Poor Settings was introduced with the
xplicit purpose of counteracting ethics dumping and encouraging equi-
able relationships between HIC and LMIC researchers and institutions
 Global Code of Conduct for Research in Resource-Poor Settings, 2018 ).
t comprises 23 articles, or recommendations, founded on the princi-
les of “fairness, respect, care and honesty ” ( Global Code of Conduct
or Research in Resource-Poor Settings, 2018 ). Respecting these four
rinciples forms the basis of a foundation of trust between stakeholders
n collaborative research and is more likely to ensure that research is
quitable. 
An approach used by ENIGMA, to ensure equity and diversity of geo-
raphic and cultural representation in their projects, is to have working
roups and other aspects of collaboration led by scientists from a range
f different countries. For example, one of the ENIGMA working groups
s led from Russia and there have been regular workshops in Moscow
nd Siberia ( Namazova-Baranova et al., 2017 , ENIGMA-Skoltech Inter-
ational Workshop, 2016 ). Another recent ENIGMA initiative led by in-
estigators in an LMIC country is the ‘India ENIGMA Initiative for Global
ging and Mental Health’, which involves large-scale data collection
n Bangalore, India. A key goal of the project is to train emerging and
stablished scientists in India, with targeted biostatistical and imaging
orkshops to bolster capacity and training in setting up international
rojects ( John et al., 2019 ). A related biobanking effort by the c-VEDA
onsortium in India (cveda.org) has led to a coordinated study of brain
evelopment in adolescence across 7 sites. A key goal of this effort is
o study effects on the brain of environmental risk factors that may be
pecific to emerging societies, including “exposure to nutritional stress,
nvironmental neurotoxins and culturally dependent forms of psychoso-
ial stress ” ( Zhang et al., 2020 ). 
.2. Data sharing: Equity and privacy 
With the formation of global neuroimaging consortia involving
ulti-site collaboration, neuroimaging studies have been able to partic-
pate in big data research with the collection, storage, analysis and shar-
ng of vast swathes of information about human behaviour, health and
isease ( Smith and Nichols, 2018 ). Big data science is an efficient and
ost-effective way of acquiring, integrating and disseminating knowl-
dge ( Murdoch and Detsky, 2013 ). In biomedical research, it has long-
erm potential for considerable improvements in health care outcomes
 Luo et al., 2016 ). While sample sizes of individual imaging studies re-
ain small, meta-analytic approaches, as used by ENIGMA, enable the
haring and pooling of a large amount of analyzed data from numerous
tudies conducted across sites, using standardized protocols that enable
ross-site harmonization of methods ( Thompson et al., 2014 ). While some form of data sharing is a prerequisite for multi-site col-
aboration, it elicits ethical concerns related to equity, privacy, informed
onsent and governance ( Vayena and Blasimme, 2018 ). We discuss the
rst two areas of concern. Data sharing is ethically justified by the prin-
iples of justice and beneficence ( Bezuidenhout and Chakauya, 2018 ).
ore specifically, it has the potential to rapidly advance scientific
rogress as it enables widespread use of data by a range of scientists
rom different disciplines, it facilitates “collaboration, transparency, …,
eproducibility ” and accountability in science ( Milham et al., 2018 ) and
educes unnecessary effort and waste of resources associated with the
eplication of data sets Figueiredo 2017 . For these reasons, science fun-
ers strongly support data sharing and scientific journals are increas-
ngly asking for data to be deposited in an open access database at the
ime of publication ( Gewin, 2016 , Policy on data, software and materials
anagement and sharing, 2017 ). 
Despite widespread support by researchers ( Kessler, 2018 ) and ben-
fits that address the reproducibility crisis in science ( Baker, 2016 ),
mong others, data sharing poses technical and ethical challenges. Spe-
ialized expertise is required to store, manage and analyze data which
ay be initially costly for laboratories to implement ( Figueiredo 2017 ).
ulti-site collaborations, in particular, may struggle with technical chal-
enges regarding different institutional regulations and requirements
ertaining to data sharing ( Boland et al., 2017 ). These may include:
aterial Transfer Agreements (MTAs) and Limited Data Use Agreements
DUAs); the General Data Protection Regulation (GDPR) in Europe; dif-
erences in consent forms regarding sharing of data or derived data,
onditional on other oversight (e.g. bilateral IRB assent); and MoUs
or collaboration that address data access. Moreover, data acquired
rom clinical populations may impose additional constraints and lim-
ts on data sharing which require consideration. More fundamentally,
owever, data sharing challenges traditional conceptions of intellectual
wnership ( Alter and Gonzalez, 2018 ). A common concern by scien-
ists is that they fear being “‘scooped’ with their own data ” ( Alter and
onzalez, 2018 ), or that their data will be misused or misinterpreted
 Figueiredo, 2017 ). 
Investigators in LMICs may be at particular risk regarding some of
he above concerns. The formation of the African Open Science Platform
nitiative (AOSP) in 2016, with the aim of furthering open science and
esearch collaboration in Africa, indicates clear support for the ethos of
ata sharing ( African Open Science Platform. April, 2019 ). That said,
MIC researchers experience challenges that pose obstacles to their par-
icipation in the open science movement. In particular, LMIC and HIC
esearchers differ in their access to resources, technical support and in-
rastructural provisions ( Bezuidenhout and Chakauya, 2018 ). LMIC re-
earchers may, for example, face problems such as slow or intermittent
nternet speeds, outdated software and/or hardware and power disrup-
ions; challenges which are not experienced in HICs ( Bezuidenhout et al.,
016 ). Discussions that engage with challenges experienced in data shar-
ng in HICs are therefore not likely to be portable to LMICs. This is
vident in the fact that because most discussions of data sharing have
aken place in HICs, they have focused on challenges arising from dif-
erences between kinds of data as opposed to differences between re-
earch contexts ( Zewail, 2010 ). In keeping with surveys conducted in
ICs which have investigated perceptions of benefits and risks of data
haring among scientists ( Stuart et al., 2018 ), a survey from 13 sub-
aharan African countries showed that scientists recognise data shar-
ng to be a way of increasing the “impact and visibility ” of their re-
earch ( Bezuidenhout and Chakauya, 2018 ). However, sub-Saharan sci-
ntists differ from their HIC counterparts in also regarding data shar-
ng as a way of supporting “future personal connections ” with known
nd trusted colleagues, rather than with strangers ( Bezuidenhout and
hakauya, 2018 ). Fears of scooping and misuse were equally present
n this cohort, particularly given concerns that research takes longer in
MICs and researchers produce fewer publications on average. 
This information has important implications. If greater uptake of
pen science and data sharing is to be encouraged in LMICs as a scien-































































































































I  ific good, the consortium approach is clearly one of the ways in which
his can be achieved, given the value placed on trust and established
onnections among LMIC scientists. Four elements of ethical data shar-
ng in LMICs have been proposed: “assessing the value of sharing ” by
ngaging with all stakeholders; “minimizing harm ” to participants and
opulations; “promoting fairness and reciprocity ” by protecting the in-
erests of local researchers and ensuring that research is relevant to the
ealth needs of communities; and developing trust between all stake-
olders ( Bull et al., 2015 ). Moreover, priority must be given to further
esearch of broad consent procedures, devising governance models and
ata sharing policies, and capacity building ( Bull et al., 2015 ). 
In terms of incentivizing data sharing at an individual level, consor-
ia should address scooping concerns with solutions tailored to LMIC re-
earchers and the challenges specific to their contexts. Certain consortia
ave successfully implemented embargo periods so that scientists have
ufficient time to publish before their data is released ( Parker et al.,
009 ). “Embargo flexibility ” entails tailoring embargo agreements to
he requirements of researchers and their disciplines and recognizes the
right of first use ” of their data ( Roche et al., 2014 ). In ENIGMA, for
xample, the sharing of data with other members is entirely optional,
ut the maximum use of the data is facilitated, subject to any prevailing
erms of consent regarding data use, data security requirements, sub-
ect to oversight of appropriate IRBs and any international agreements.
nsofar as they stipulate how data are able to be used, data usage agree-
ents (DUAs) are helpful in protecting the interests of researchers and
articipants, however, in the context of multi-site collaborations and
ultiple agreements, if DUAs are excessively complex, this increases the
dministrative burden and may impede progress ( Sarwate et al., 2014 ).
nother way in which data sharing may be incentivized is by ensuring
o-authorship on all derived papers. 
While the ethical concerns associated with data sharing are not
nique to imaging genetics, brain and genetic data represent funda-
entally personal and potentially sensitive information about human
eings. A frequently voiced ethical concern regarding data sharing is
herefore the impact it may have on the privacy of research participants.
hile consortia such as the PGC use mega-analysis approaches, ENIGMA
as primarily used meta-analysis ( Thompson et al., 2014 ). The meta-
nalysis approach addresses privacy concerns, to a large extent, and is
n line with ethical guidelines and legal restrictions in certain countries
egarding the sharing of personal data of participants ( Thompson et al.,
014 ). This approach is also ethically commendable as site members
etain ownership of their data and are responsible for protecting the
rivacy of participants. That said, the risk of privacy breaches remains
ecause despite the fact that summary statistics shared through meta-
nalysis contain deidentified information, various methods have been
sed to demonstrate that participants may be reidentified from pooled
ata ( Homer et al., 2008 , Schadt et al., 2012 , Gymrek et al., 2013 ). How-
ver, it has been argued that de-identification or ensuring anonymity
quates with ensuring that the likelihood of matching “a correct iden-
ity to a record in a dataset is very small ” ( El Emam et al., 2015 ). 
De-identification of data is primarily aimed at protecting the per-
onal information associated with individual research participants.
owever, a related concern associated with population studies, which
ould be intensified in the case of neuroimaging genetics studies, is that
he disclosure of potentially sensitive information about particular pop-
lations or communities could have negative implications for such pop-
lations ( de Vries et al., 2012 ). A well-documented example of this oc-
urred with the publication of a comparison between the genome se-
uence of a member of the ‘Khoisan’ people, “the oldest known lineage
f modern human ” and “a Bantu from Southern Africa ” ( Schuster et al.,
010 ). The study aimed to deepen understanding of genetic diversity
y investigating and comparing common variants. What was problem-
tic about this study was the unsubstantiated and unrelated inferences
ade in an additional paper, published with the study and supposedly
ased on it. This paper contained information and cultural inferences
hat San community leaders found to be “private, pejorative, discrimi-atory and inappropriate ” ( Chennells and Steenkamp, 2018 ). The ex-
loitative nature of this study and the negative implications for the
opulation in question of sharing what was deemed to be information
f a “sensitive and private nature ” highlights the importance of com-
unity engagement prior to and during research and the need for ade-
uate, contextually informed, assessment of possible risk ( Chennells and
teenkamp, 2018 ). Certain studies, e.g. population-level neuroimaging
enetics studies of cognitive performance, that may be subject to mis-
nterpretation, require ethical safeguards to be put in place ( Gray and
hompson, 2004 , Gray and Thompson, 2004a ). Such ethical safeguards
nclude: securing the consent of target groups via “appropriate represen-
atives ”, full disclosure to participants of the study’s aims, the option to
ithdraw and have one’s data destroyed or removed from databases,
nd appropriate care taken with descriptions and communication of
ndings ( Gray and Thompson, 2004 ). 
A few observations can be made from our discussion that are rele-
ant for global collaborations. First, given the contextual challenges and
mplications associated with data sharing, it is unlikely that a one-model
r standardized approach to governance will be appropriate. To mini-
ize risk and ensure maximum benefit for all concerned, data sharing
pproaches must be adaptable for diverse research contexts ( Nicol et al.,
019 ). Second, to address privacy concerns and balance them with
he importance of data sharing, greater consideration is needed of the
iews of all stakeholders, including research participants themselves.
arious studies have investigated privacy concerns of research partic-
pants regarding both deidentified and open genomic data sharing in
arious HICs ( Shah et al., 2019 , Goodman et al., 2017 , McGuire et al.,
011 ). However, as there have been limited studies of this kind in LMICs
 Parker and Bull, 2015 ), further work is needed in this context. 
. The potential impact of neuroimaging genetics research 
ndings in LMICs 
Over and above internal issues associated with the collaborative pro-
ess, the findings generated by neuroimaging genetics collaborations
ave wider implications for research participants, their families and
heir communities. We next examine dilemmas associated with feedback
f findings and the risk of essentializing and stigmatizing interpretations
f imaging genetics research. 
.1. Feedback of findings 
By participating in neuroimaging genetics studies, research partici-
ants are contributing to knowledge of the pathogenesis of neuropsychi-
tric disorders. If this research yields findings that have clinical poten-
ial, it may ultimately lead to long-term collective benefits for persons
ith such disorders. However, given that participation will not produce
irect benefits for participants, there is, arguably, an obligation to recog-
ise their contributions by providing any benefits that are reasonably
ossible. This is in keeping with a recognition of the importance of reci-
rocity which has gained traction as a protective mechanism in research
 Tindana et al., 2019 , Maiter et al., 2008 , Trainor and Bouchard, 2013 ).
ne way of ensuring that participation is beneficial to participants is to
rovide feedback of findings where appropriate ( National Academies of
ciences Engineering and Medicine 2018 , Illes et al., 2006 ). In the case
f experimental results there is agreement that only “high quality re-
earch results ” ( Botkin et al., 2018 ) or those that are “clinically … valid,
nd reliable ” ( National Academies of Sciences Engineering and Medicine
018 ) should be shared with participants. 
While neuroimaging genetics studies currently generate data with
opulation-level significance, imaging may detect the presence of inci-
entalomas (asymptomatic tumours or other abnormalities) or other in-
idental findings (e.g. aneurysms) unrelated to the research question,
hat may have clinical significance ( Illes et al., 2004 , Buchman and
lles, 2010 ). Where such incidental findings deliver reliable, clinically

































































































































n  ctionable information, there is a moral obligation to deliver such re-
ults in our opinion. Analogous considerations hold in genetics re-
earch. However, systematic reviews indicate that the prevalence of
alignancy in incidentalomas is less than 5% for brain incidentalomas
 O’Sullivan et al., 2018 ). This creates a dilemma regarding the shar-
ng of such information, given the negative outcomes of overdiagno-
is ( Chojniak, 2015 ). In particular, sharing such information may cause
cute anxiety for participants, leading to unnecessary treatments and
verburdening health care systems ( O’Sullivan et al., 2018 ). 
These risks and burdens are likely to be intensified in collabora-
ive research involving studies in LMICs. Moreover, standardized ap-
roaches to feedback developed in HICs are unlikely to be appropri-
te or implementable in such contexts ( Sullivan and Berkman, 2018 ,
rtiz-Osorno et al., 2015 ). A finding that is actionable in a HIC may
ot be actionable in a resource-strained context. A protocol-by-protocol
pproach has been suggested as a more appropriate way of responding
o the challenges of feeding back findings in areas such as genomics
esearch which are subject to continual change and a lack of certainty
 Weiner, 2014 ). This approach would also seemingly address contextu-
lly specific feedback challenges. While it is recognized that collabora-
ions must seek to balance the need for consistency in research and ethics
ractices across the network with appropriate response to diversity in
ocal contexts ( Parker and Bull, 2009 ), feedback approaches that differ
cross sites, on the basis of access to healthcare resources, risk exacer-
ating inequities and are therefore unjust. However, providing feedback
f an actionable finding in a context where access to requisite treatment
nd care is lacking is equally problematic. This seemingly intractable
ilemma may require falling back on a nuanced, contextually informed,
alculation of the benefits and harms of disclosure and a provision of
lternative benefits where potential harms of disclosure are likely to be
xcessive ( Sullivan and Berkman, 2018 ). 
.2. Essentialism and stigma 
While there is much overlap between the ethics generated by genetic
nd brain research respectively, the latter arguably elicits qualitatively
istinct concerns ( Roskies, 2007 , Illes and Racine, 2005 ). This is pre-
ominantly attributable to the tendency to regard the mind and the
rain as constitutive of highly valued, metaphysical concepts such as
ersonal identity, the self, free will and moral capacity. It is also the ba-
is of the premise that the ethical and philosophical issues generated by
rain research and interventions are sufficiently unique, in comparison
ith other areas of medical research and practice, to treat neuroethics
s a distinct area of focus, in its own right. Moreover, the mind and the
rain are inextricably related in such a way that it is easy to see how
n essentialist view of the brain arises. In the absence of brain func-
ion there can be no higher-order mental function. Neuro-essentialism,
akes a leap beyond this observation and espouses the view that psy-
hological states and experience are best explained with reference to
rain states and function and that psychiatric disorders are disorders of
he brain ( Schultz, 2015 ). On such a view the mind is synonymous and
educible to the brain. 
Genotypes, their expression in observable brain morphology, and
henotypes, form a complex, non-linear causal chain that is impacted
y environmental interactions. In comparison with brain morphology,
enes are possibly more causally distant from neuropsychiatric pheno-
ypes ( Roskies, 2007 ). Despite this distance, genethics must contend
ith its own distinct ethical issues. Awareness of the relatively stable,
eritable and fundamentally unique nature of the human genome is also
ikely to lead to essentialist views ( Kong et al., 2017 , Dar-Nimrod and
eine, 2011 ). Genetic-essentialism refers to the tendency to overesti-
ate the genetic basis of behaviour, traits, health and disease, while
ownplaying the role played by environment ( Phelan et al., 2013 ). Stud-
es, mostly conducted in HICs, indicate that information about genes
nd the brain is frequently interpreted through an essentialist lens Parrott et al., 2012 , Gould and Heine, 2012 ). Given that imaging ge-
etics studies are explicitly focused on the relationship between genes
nd the brain in conferring risk for neuropsychiatric disorders, it is easy
o understand how communication about this research may be inter-
reted by participants and communities in essentialist ways. What is
herefore, arguably, unique in neuroimaging genetics research is how
he confluence of these two areas that are particularly susceptible to
ssentialist interpretations may heighten risk for various misinterpreta-
ions ( Tairyan and Illes, 2009 ). 
This is important because essentializing interpretations are problem-
tic insofar as they support other reductionist views. First, essentialism
enerally entails oversimplifying or reducing something that is complex
n its cause, structure or function, e.g. understanding mental disorders
urely or predominantly in terms of a biological model rather than ac-
nowledging psychosocial determinants. Second, essentialism can lead
o determinism which, in this context, is the view that if mental disor-
ers are caused by genotype and neurophysiology, factors over which we
ave little to no control, there is little to no room for agency. Determinist
nterpretations also impact assessments of risk or probability with the
esult that information about risk may be regarded as implying more cer-
ainty than is warranted ( Illes and Racine, 2005 , Palk et al., 2019 ) This
an engender a sense of powerlessness or fatalism ( Shen et al., 2009 ).
hird, and connected with the previous points, essentialist interpreta-
ions of neuroimaging genetics findings may exacerbate stigma towards
ental disorders ( Tairyan and Illes, 2009 , Illes and Racine, 2005 ). This
ould be the case if beliefs about mental disorders as being ‘in the genes
nd the brain’ lead to the view that persons with such disorders, and
heir relatives by association ( Catthoor et al., 2015 ), are inherently dif-
erent. This risk is considerable, given the high levels of stigmatization
f mental disorders in particular regions of the globe ( World Health Or-
anization, 2018 ). 
The causes of stigma associated with mental disorders and the way
n which it is manifested differ across the globe, but within Africa its
ources are generally consistent and identifiable. High levels of stigma
re predominantly attributed to fear and hostility arising from cultur-
lly informed beliefs regarding the aetiology of mental disorders, e.g.,
eliefs about spiritual causes such as witchcraft, demonic possession,
etribution or the view that symptoms and behaviours are deliberate or
ndicate weakness or incorrigibility ( Egbe et al., 2014 , Kapungwe et al.,
010 , Gureje et al., 2005 , Shibre et al., 2001 , Shah et al., 2017 , Opare-
enaku and Utsey, 2017 , Palk and Stein, 2020 ). External factors and
otions of responsibility thus play an important role in stigmatizing as-
riptions in these contexts. Stigmatizing beliefs about external or spir-
tual causes are challenging to address because they can be reconciled
ith information about the biological basis of mental disorders, by ex-
ending the perceived causal chain to encompass the latter. Moreover,
ddressing different, culturally informed, explanatory models of disease
equires sensitivity. 
In terms of a connection between responsibility and stigma, biolog-
cal or genetic models of mental disorder may lead to more acceptance
ecause they have a tendency to feed into essentialist, determinist in-
erpretations or, at least, to less blame and, ultimately a decrease in
tigma. However, a systematic review of 33 studies conducted in both
IC and LMICs that focused on this question found that in most cases,
iogenetic explanations of mental disorder did not increase acceptance
 Angermeyer et al., 2011 ). Findings also confirm that stigma, mani-
ested as a desire for social distance, is mostly informed by percep-
ions of “dangerousness and unpredictability ” ( Angermeyer et al., 2011 ,
vaale et al., 2013 ). These findings were echoed in a meta-analysis of
6 studies which found that neurobiological explanations were also as-
ociated with increased stigma, reflected in an increased desire for so-
ial distance from individuals with mental disorders ( Loughman and
aslam, 2018 ). However, findings also indicated that responses to bio-
enetic explanations were impacted by culture and the nature of the dis-
rder in question ( Angermeyer et al., 2011 ). In non-Western contexts,
egative stereotypes may be more strongly informed by perceptions of


















































































































esponsibility. It is important, therefore, that discussions of genetic neu-
oimaging findings highlight the importance of a non-reductionistic and
on-essentialist perspective, in order to counter such views. This is also
mportant when scientists relay findings to the media ( Racine et al.,
005 , Racine et al., 2006 ), which often adopts an essentialist
erspective. 
. Concluding remarks – African ethics perspectives as a resource 
We conclude with some suggestions informed by ethical perspec-
ives that are prevalent in sub-Saharan Africa. We use the term African
thics simply for ease of reference, while noting the diversity of norma-
ive perspectives found on the African continent. In the same way that
here is no definitive Western ethics, there is no singular African ethics.
owever, there are certain themes that are sufficiently prevalent, that
escriptions of African perspectives as largely communitarian or West-
rn perspectives as predominantly individualist are coherent. Insights
rawn from these themes may be a useful resource for thinking through
ome of the challenges that we have highlighted. 
Communitarianism is a widespread worldview that recognizes and
erives normative implications from the relational nature of human exis-
ence. African communitarian perspectives are informed by the under-
ying view that personhood is, and should be, relationally constituted
nd maintained. The way one relates with others is therefore funda-
entally important; social values such as harmony, good will, connec-
ion, interdependence, accountability, and reciprocity are guiding ideals
 Metz, 2007 ). The ethos of a communitarian position and its associated
deals is well captured by the notion of solidarity. The value of solidar-
ty as a necessary addition to the dominant bioethics paradigm has also
een recognised in global health ethics discussions ( Benatar et al., 2016 ,
osam et al., 2018 , Andoh, 2011 ). 
As an intrinsically relational value, solidarity is a powerful ideal. It
s grounded by the premise that respecting and cultivating connections
s good as an end, in itself, rather than as a means to an end. While the
bility of an appeal to values, principles or ideals to address some of
he issues we have discussed may be limited; the addition of a relational
otion, such as solidarity, to the dominant bioethics paradigm has great
otential to address some of the internal issues associated with collabo-
ative research that we have highlighted. In global collaborations aimed
t improving health, an emphasis on solidarity is in keeping with recog-
ition of the historical context that has led to global health inequities
nd justifies an obligation to redress these by supporting and building
he capacity of researchers and institutions in low-resourced contexts.
n the context of neuroimaging genetics studies, solidarity would jus-
ify investment in the infrastructure, equipment, and skill necessary to
chieve greater representation of low-resourced contexts. ENIGMA has
one this, for example, by mentoring a range of individuals in these
ontexts. Cultivating solidarity in collaborative research will lead to
tronger, more equitable, connections between researchers and sites. An
thos of solidarity is also congruent with reciprocity-based approaches
o research that is mutually beneficial for stakeholders and responsive
o local needs. Solidarity also justifies inclusivity and genuine partici-
ation of local communities and populations in ensuring this latter re-
uirement. 
Our aim in this paper is to draw attention to both the opportunities
nd heightened risks posed by the convergence of neuroimaging and
enetics, and the need for appropriate caution in global collaborations.
ur discussion has not aimed to be exhaustive; there is an abundance
f literature addressing the areas we have highlighted. We emphasize
hat concerns for stigma and equity are key ongoing ethical challenges
or neuroimaging genetics collaborations. Here we have provided a the-
retical approach based on the framework of communitarianism as a
esource to discuss such challenges, and we offer a number of practical
ecommendations to decrease stigma and increase equity. eclaration of Competing Interest 
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